Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Monoclonal antibodies: From magic bullet to precision weapon

11 Oct 2024

Abstract excerpt

Monoclonal antibodies (mAbs) are used to prevent, detect, and treat a broad spectrum of non-communicable and communicable diseases. Over the past few years, the market for mAbs has grown exponentially with an expected compound annual growth rate (CAGR) of 11.07% from 2024 (237.64 billion USD estimated at the end of 2023) to 2033 (679.03 billion USD expected by the end of 2033). Ever since the advent of hybridoma...

Topics

Join the communities discussing this publication.

Monoclonal and Polyclonal Antibodies Research
Protein purification and stability
T-cell and B-cell Immunology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39390211
DOI: 10.1186/s43556-024-00210-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monoclonal antibodies: From magic bullet to precision weaponPMID 39390211Read ↗

Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable PatientsSemantic proximity Read ↗

Therapeutic antibodies for human diseases at the dawn of the twenty-first centurySemantic proximity Read ↗

Mechanism of Action and Pharmacokinetics of Approved Bispecific AntibodiesSemantic proximity Read ↗

Antibody Structure and Function: The Basis for Engineering TherapeuticsSemantic proximity Read ↗

Antibody therapeutics:Semantic proximity Read ↗

Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges.Semantic proximity Read ↗

Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in ImmunotherapySemantic proximity Read ↗

Monoclonal Antibody Therapeutics for Infectious Diseases: Beyond Normal Human ImmunoglobulinSemantic proximity Read ↗

The Challenges and Breakthroughs in the Development of Diagnostic Monoclonal AntibodiesSemantic proximity Read ↗

Beyond antibodies: using biological principles to guide the development of next-generation protein therapeuticsSemantic proximity Read ↗

Overcoming Variants Resistance in Monoclonal Antibody for Antiviral TherapySemantic proximity Read ↗

Immunogenicity of Therapeutic Antibodies: Mechanisms, Prediction, and Mitigation Strategies in the Era of Personalized BiologicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.